4//SEC Filing
LIDGARD GRAHAM PETER 4
Accession 0001209191-21-016476
CIK 0001124140other
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 7:00 PM ET
Size
11.0 KB
Accession
0001209191-21-016476
Insider Transaction Report
Form 4
LIDGARD GRAHAM PETER
SVP, Chief Scientific Officer
Transactions
- Exercise/Conversion
Restricted Stock Units
2021-02-26−3,263→ 6,526 total→ Common Stock (3,263 underlying) - Sale
Common Stock
2021-03-01$137.44/sh−1,603$220,316→ 42,989 total - Exercise/Conversion
Common Stock
2021-02-26+3,263→ 44,592 total
Holdings
- 12,725(indirect: By 401(k))
Common Stock
- 4,673(indirect: By Trust)
Common Stock
Footnotes (5)
- [F1]Represents shares of common stock received upon vesting of a restricted stock unit award.
- [F2]Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain restricted stock units on February 26, 2021.
- [F3]In addition to the shares of Common Stock reported on this Form 4, which total 60,387 shares, Mr. Lidgard also holds, in the aggregate, an additional 116,630 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.
- [F4]Each restricted stock unit represents a contingent right to receive one share of common stock.
- [F5]Represents a restricted stock unit award granted on February 26, 2019 that partially vested on February 26, 2021. The restricted stock units vest in four equal annual installments beginning on February 26, 2020.
Documents
Issuer
EXACT SCIENCES CORP
CIK 0001124140
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001216274
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 7:00 PM ET
- Size
- 11.0 KB